| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/12/2003 | EP1282413A1 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/12/2003 | EP1282402A1 Stabilized aqueous suspensions for parenteral use |
| 02/12/2003 | EP1189899B1 Pyrazinone thrombin inhibitors |
| 02/12/2003 | EP1140984B1 Selective inhibitors of mmp-12 |
| 02/12/2003 | EP1109534B1 Quick release pharmaceutical compositions of drug substances |
| 02/12/2003 | EP1064262B1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 02/12/2003 | EP1049703B1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1beta converting enzyme |
| 02/12/2003 | EP1042355B1 11beta-halogen-7alpha-substituted estratrienes, method for producing pharmaceutical preparations containing said 11beta-halogen-7alpha-substituted estratrienes and use of the same for producing medicaments |
| 02/12/2003 | EP1023314B1 Bile acid salts of metals with physiological action and the use thereof in therapy |
| 02/12/2003 | EP0988292B1 Piperazine derivatives and their use as anti-inflammatory agents |
| 02/12/2003 | EP0980374B1 Phosphodiesterase 4-inhibiting diazepinoindolones |
| 02/12/2003 | EP0966299B1 Novel oral formulations of calcitonin |
| 02/12/2003 | EP0944601B1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 02/12/2003 | EP0941112B1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors |
| 02/12/2003 | EP0871623B1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 02/12/2003 | EP0871456B1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd |
| 02/12/2003 | EP0770079B1 Heterobicyclic derivatives |
| 02/12/2003 | CN1396923A 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 02/12/2003 | CN1396922A Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl acetic acid |
| 02/12/2003 | CN1396921A Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of 5-HT7 reactor |
| 02/12/2003 | CN1396920A 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 02/12/2003 | CN1396915A Heterocylic derivative, its preparation method and medicine composition containing them |
| 02/12/2003 | CN1396912A 2-amino-nicotinamide derivative sand their use as VEGF-receptor tyrosine kinase inhibitors |
| 02/12/2003 | CN1396909A Inhibitors of ICE/ced-3 family of cysteine protease |
| 02/12/2003 | CN1396906A Calcilytic compounds |
| 02/12/2003 | CN1396904A Novel compound, their preparation and use |
| 02/12/2003 | CN1396823A Electrospun pharmaceutical compositions |
| 02/12/2003 | CN1396176A Method for purifying drug active protein by cation exchange chromatogrphy |
| 02/12/2003 | CN1396165A Zilpaterol hydrochcoride monohydrate |
| 02/12/2003 | CN1395966A Antisanility Chinese patent medicine |
| 02/12/2003 | CN1395946A Chinese medicine for relieving fatigue |
| 02/12/2003 | CN1395945A Medical wine for nourishing kidney and growing hair and its preparing process |
| 02/12/2003 | CN1395935A Citicoline sodium injection for intravenous injection and its preparing process |
| 02/12/2003 | CN1395926A Application of p-bis (n-alasulfonyl) benzoic acid in veterinary medicine |
| 02/12/2003 | CN1101392C Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quindinone derivatives |
| 02/12/2003 | CN1101391C Farnesyl transferase inhibiting 2-quinolone derivatives |
| 02/12/2003 | CN1101384C Process for preparing 1-biphenylmethylmidazole derivatives |
| 02/12/2003 | CN1101223C Production process for whole glossy ganoderma |
| 02/12/2003 | CN1101210C Health-preserving capsule |
| 02/12/2003 | CN1101207C Preparation of serial healthy foods with peach blossom, pearl and ant |
| 02/12/2003 | CN1101186C Broiler ascites preventive agent and method of preventing ascites |
| 02/11/2003 | US6518450 Guaiacoxypropanolamines with alpha/beta adrenergic blocking activity |
| 02/11/2003 | US6518432 The invention relates to a novel process for the preparation of certain pharmaceutically active pyridyl compounds. NMDA receptor antagonist activity. The compound known as (S)-1-phenyl-2-(2- pyridyl)ethanamine is of particular |
| 02/11/2003 | US6518429 Anticancer agents, treating restenosis, atherosclerosis and hepatitis virus |
| 02/11/2003 | US6518427 Compounds are exceedingly water soluble which is useful in preparing pharmaceutical formulations of these compounds. They are also rapidly converted back to the parent amines in vivo, making them useful as prodrugs of the parent amines. |
| 02/11/2003 | US6518412 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 02/11/2003 | US6518316 Cytokine production and tyrosine kinase inhibitors |
| 02/11/2003 | US6518306 PDE4 inhibitors particularly in regards to treating allergic and inflammatory diseases |
| 02/11/2003 | US6518302 Remedies |
| 02/11/2003 | US6518291 Inosine-5'-monophosphate dehydrogenase inhibitors |
| 02/11/2003 | US6518290 Substituted oxazoles and thiazoles derivatives as HPPAr alpha activators |
| 02/11/2003 | US6518286 Compounds |
| 02/11/2003 | US6518283 Squaric acid derivatives |
| 02/11/2003 | US6518277 Disrupting leukocyte function |
| 02/11/2003 | US6518269 Cancer treatment |
| 02/11/2003 | US6518268 Telomerase inhibitors and methods of their use |
| 02/11/2003 | US6518267 Protease inhibitors |
| 02/11/2003 | US6518265 1H-imidazopyridine derivatives |
| 02/11/2003 | US6518238 Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3 |
| 02/11/2003 | US6518046 DNA (RNA) encoding such chemolcine polypeptides. Moreover, a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such Ck beta -9 polypeptides for the treatment of |
| 02/11/2003 | US6518043 Proteins suppressing proliferation of lympho-hematopoietic cells |
| 02/11/2003 | US6517871 Amorphous ammonium salt; blocking angiotensin II receptors; treating hypertension, congestive heart failure and renal failure |
| 02/11/2003 | US6517843 Recombinant immunogen comprised of an inactivated porcine circovirus-2 |
| 02/11/2003 | US6517828 C-CAM as an angiogenesis inhibitor |
| 02/11/2003 | US6517795 Process for producing hydrotalcites and the metal oxides thereof |
| 02/11/2003 | CA2216851C Radiolabeled peptides for diagnosis and therapy |
| 02/11/2003 | CA2205274C Novel 2,3 disubstituted-(5,6)-heteroarylfused-pyrimidine-4-ones |
| 02/11/2003 | CA2174529C Dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) and uses thereof |
| 02/11/2003 | CA2141554C Morphogen-induced nerve regeneration and repair |
| 02/11/2003 | CA2125476C 20-methyl-substituted vitamin d derivatives |
| 02/11/2003 | CA2085584C Treatment of chronic renal failure with imidazole angiotensin-ii receptor antagonists |
| 02/11/2003 | CA2071375C Heterocyclic derivatives |
| 02/10/2003 | WO2002014320A2 Novel substituted diaryl azepine derivatives as integrin ligands |
| 02/10/2003 | CA2419078A1 Substituted diaryl azepine derivatives as integrin ligands |
| 02/07/2003 | WO2002014309A1 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof |
| 02/07/2003 | CA2418790A1 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof |
| 02/07/2003 | CA2354743A1 Mitochondrially targeted antioxidants |
| 02/06/2003 | WO2003010315A1 Abca7 splicing variant |
| 02/06/2003 | WO2003010306A1 Viral mutants that selectively replicate in targeted human cancer cells |
| 02/06/2003 | WO2003010303A1 Methods of inducing differentiation of stem cells |
| 02/06/2003 | WO2003010301A1 New isolated dendritic cells, a process for preparing the same and their use in pharmaceutical compositions |
| 02/06/2003 | WO2003010299A1 Probiotic lactobacillus casei strains |
| 02/06/2003 | WO2003010290A2 Novel class ii cytokine receptors and uses thereof |
| 02/06/2003 | WO2003010281A2 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 02/06/2003 | WO2003010243A2 Multipotent stem cells from peripheral tissues and uses thereof |
| 02/06/2003 | WO2003010196A2 Variants and exons of the glyt1 transporter |
| 02/06/2003 | WO2003010188A1 Production of high molecular mass lectins |
| 02/06/2003 | WO2003010180A1 Methods and compositions for rnai mediated inhibition of gene expression in mammals |
| 02/06/2003 | WO2003010168A1 4-oxoimidazolidine-2-spiropiperidine derivative |
| 02/06/2003 | WO2003010167A1 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands |
| 02/06/2003 | WO2003010159A1 Piperidine derivatives as nmda receptor antagonists |
| 02/06/2003 | WO2003010158A1 Novel compounds |
| 02/06/2003 | WO2003010152A1 Novel crystal of arylethenesulfonamide derivative and process for producing the same |
| 02/06/2003 | WO2003010141A2 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure |
| 02/06/2003 | WO2003010140A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 02/06/2003 | WO2003010135A1 Novel phenylpropionic acid derivatives |
| 02/06/2003 | WO2003010132A1 N-[(1-dimethylaminocycloalkyl)methyl]benzamide derivatives |
| 02/06/2003 | WO2003009859A1 Immunotherapy for humans |
| 02/06/2003 | WO2003009849A1 Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor |
| 02/06/2003 | WO2003009848A1 Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses |